Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $106
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Medtronic and raised the price target from $105 to $106.
August 21, 2024 | 1:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo has maintained an Overweight rating on Medtronic and increased the price target from $105 to $106, indicating a positive outlook.
The increase in price target and maintained Overweight rating by Wells Fargo suggests a positive sentiment towards Medtronic's stock, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100